Increased expression of miR-155 promotes neuronal autophagy in the diseased brain, which is beneficial to many neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, by eliminating deposited toxic proteins, such as APP/Aβ and α-synuclein. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.